← Open Payments lookup

KATIE MONTGOMERY: Open Payments

NPI 1841845286 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,151 in 55 payments from 18 companies in 2025. Trend: 2023 $16,764 · 2024 $1,103 · 2025 $2,151

Food & beverage: $2,151
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.11$409
AstraZeneca Pharmaceuticals LP9$381
Amgen Inc.5$283
Boehringer Ingelheim Pharmaceuticals, Inc.8$250
Novo Nordisk Inc2$150
Dexcom, Inc.1$122
GENZYME CORPORATION1$103
AKEBIA THERAPEUTICS INC1$86
Calliditas Therapeutics US Inc.4$81
Xeris Pharmaceuticals, Inc.3$69

Products named: Kerendia, JARDIANCE, FARXIGA, KRYSTEXXA, Wegovy, TAVNEOS, DEXCOM G7 GSS (161), FABRAZYME.

Industry payments across TX — which companies pay providers there.